Disc Medicine (IRON) Valuation Check As Bitopertin Wins Priority FDA Review And Commercial Plans Advance

Disc Medicine (IRON) has drawn fresh attention after securing priority FDA review for bitopertin and outlining ...

Is Disc Medicine (IRON) Offering An Opportunity After Recent Volatility And DCF Valuation Gap

If you are wondering whether Disc Medicine is attractively priced at around US$79.02, it helps to step back and look at what ...
Investor's Business Daily on MSN

Disc Medicine reaches 80-plus relative strength rating benchmark

Disc Medicine sees its Relative Strength Rating enter the 80-plus level.
PR Newswire

Global Lumbar Disc Replacement Devices Market to Exhibit Significant Growth at a CAGR of ~9% by 2030 | DelveInsight

The increasing demand for lumbar disc replacement devices is mainly driven by the rising incidence of bone-related disorders such as osteoporosis and arthritis. Moreover, the expanding geriatric ...